Filed Pursuant to Rule 433
Registration No. 333-153696
March 9, 2010
PRICING TERM SHEET
Novartis Capital Corporation
1.900% Notes due 2013
2.900% Notes due 2015
4.400% Notes due 2020
Fully and unconditionally guaranteed by
Novartis AG
1.900% Notes due 2013: |
|
|
|
|
|
Issuer: |
| Novartis Capital Corporation |
|
|
|
Guarantor: |
| Novartis AG |
|
|
|
Size: |
| $2,000,000,000 |
|
|
|
Maturity Date: |
| April 24, 2013 |
|
|
|
Coupon: |
| 1.900% |
|
|
|
Interest Payment Dates: |
| April 24 and October 24, commencing October 24, 2010 |
|
|
|
Price to Public: |
| 99.867% |
|
|
|
Benchmark Treasury: |
| 1.375% due 02/2013 |
|
|
|
Benchmark Treasury Yield: |
| 1.394% |
|
|
|
Spread to Benchmark Treasury: |
| 55 bp |
|
|
|
Yield: |
| 1.944% |
|
|
|
Make-Whole Call: |
| Treasury Rate plus 10 bps |
|
|
|
CUSIP: |
| 66989H AB4 |
|
|
|
ISIN: |
| US66989HAC25 |
Trade Date: |
| March 9, 2010 |
|
|
|
Expected Settlement Date: |
| March 16, 2010 (T+5) |
|
|
|
Listing: |
| None |
|
|
|
Anticipated Ratings: |
| Aa2 by Moody’s Investors Service, Inc. |
|
|
|
Joint Book-Running Managers: |
| Goldman, Sachs & Co. |
|
|
|
Co-Managers: |
| BNP Paribas Securities Corp. HSBC Securities (USA) Inc. |
2.900% Notes due 2015: |
|
|
|
|
|
Issuer: |
| Novartis Capital Corporation |
|
|
|
Guarantor: |
| Novartis AG |
|
|
|
Size: |
| $2,000,000,000 |
|
|
|
Maturity Date: |
| April 24, 2015 |
|
|
|
Coupon: |
| 2.900% |
|
|
|
Interest Payment Dates: |
| April 24 and October 24, commencing October 24, 2010 |
|
|
|
Price to Public: |
| 99.522% |
|
|
|
Benchmark Treasury: |
| 2.375% due 02/2015 |
|
|
|
Benchmark Treasury Yield: |
| 2.351% |
|
|
|
Spread to Benchmark Treasury: |
| 65 bp |
|
|
|
Yield: |
| 3.001% |
|
|
|
Make-Whole Call: |
| Treasury Rate plus 10 bp |
|
|
|
CUSIP: |
| 66989H AC2 |
|
|
|
ISIN: |
| US66989HAC25 |
|
|
|
Trade Date: |
| March 9, 2010 |
|
|
|
Expected Settlement Date: |
| March 16, 2010 (T+5) |
|
|
|
Listing: |
| None |
|
|
|
Anticipated Ratings: |
| Aa2 by Moody’s Investors Service, Inc. |
|
|
|
Joint Book-Running Managers: |
| Goldman, Sachs & Co. |
|
|
|
Co-Managers: |
| BNP Paribas Securities Corp. |
4.400% Notes due 2020: |
|
|
|
|
|
Issuer: |
| Novartis Capital Corporation |
|
|
|
Guarantor: |
| Novartis AG |
|
|
|
Size: |
| $1,000,000,000 |
|
|
|
Maturity Date: |
| April 24, 2020 |
|
|
|
Coupon: |
| 4.400% |
|
|
|
Interest Payment Dates: |
| April 24 and October 24, commencing October 24, 2010 |
|
|
|
Price to Public: |
| 99.237% |
|
|
|
Benchmark Treasury: |
| 3.625% due 02/2020 |
|
|
|
Benchmark Treasury Yield: |
| 3.714% |
|
|
|
Spread to Benchmark Treasury: |
| 78 bp |
|
|
|
Yield: |
| 4.494% |
|
|
|
Make-Whole Call: |
| Treasury Rate plus 15 bp |
|
|
|
CUSIP: |
| 66989H AD0 |
|
|
|
ISIN: |
| US66989HAD08 |
|
|
|
Trade Date: |
| March 9, 2010 |
|
|
|
Expected Settlement Date: |
| March 16, 2010 (T+5) |
|
|
|
Listing: |
| None |
|
|
|
Anticipated Ratings: |
| Aa2 by Moody’s Investors Service, Inc. |
|
|
|
Joint Book-Running Managers: |
| Goldman, Sachs & Co. |
|
|
|
Co-Managers: |
| BNP Paribas Securities Corp. |
|
| Nomura Securities International, Inc. |
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer and the guarantor have filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer and the guarantor have filed with the SEC for more complete information about the issuer, the guarantor and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Goldman, Sachs & Co. at 1-866-471-2526, J.P. Morgan Securities Inc. collect at 1-212-834-4533, Banc of America Securities LLC toll-free at 1-800-294-1322, Barclays Capital Inc. at 1-888-603-5847 or by e-mailing barclaysprospectus@broadridge.com, Citigroup Global Markets Inc. toll-free at 1-877-858-5407 or Morgan Stanley & Co. Incorporated at 1-866-718-1649.